medigraphic.com

2012, Number 3

<< Back Next >>

Rev Cuba Endoc 2012; 23 (3)

Thyroid storm

Leal CL

Language: Spanish
References: 31
Page:
PDF size: 195.10 Kb.


ABSTRACT

The thyroid storm is one of the most critical situations in the endocrine emergencies and exhibits a significant mortality rate. The most common etiology of thyrotoxicosis is Graves' disease and the predominant precipitating factor is infection. The clinical characteristics are dysfunction of several systems (heat-regulator, central nervous, gastrointestinal and cardiovascular), and levels of total or free thyroid hormones that exceed the normal values. The treatment must be multidisciplinary and include support measures in intensive care units, normalization of body temperature, reduction of the production and the release of thyroid hormones by using synthesis and iodine anti-thyroid products respectively, blockade of the peripheral effects through administration of Beta-blockers and correction of the unleashing factor. Once the patients are stabilized, it is necessary to plan the final therapy that will prevent the future recurrence of the thyrotoxic crisis.


REFERENCES

  1. Jameson L, Weetman A. Disorders of the thyroid gland. In: Braunwald E, Fauci A, Kasper D, editors. Harrison's principles of internal medicine. 15th edition. New York: McGraw-Hill; 2001. p. 2060-84.

  2. Karger S, Fuhrer D. Thyroid storm-thyrotoxic crisis: an update. Deutsch Med Wochenschr. 2008;133:479-84.

  3. Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006;35:663-86.

  4. Silva JE, Bianco SD. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008;18:157-65.

  5. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21:18-9.

  6. Goldberg PA, Inzucchi SE. Critical issues in endocrinology. Clin Chest Med. 2003;24:583-606.

  7. Wong V, Xi-Li F, Geoge J. Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis. Clin Endocrinol (Oxf). 2002;56:793-8.

  8. Lin YQ, Wang X, Muthy MS. Life-threatening thyrotoxicosis induced by combination therapy with peg-interferon and ribavirin in chronic hepatitis C. Endocr Pract. 2005;11(2):135-9.

  9. Jiménez C, Moran SA, Sereti I. Graves' disease after Interleukin-2 therapy in a patient with Human Immunodeficiency Virus infection. Thyroid. 2004;14:1097-101.

  10. Wilkinson JN. Thyroid storm in a polytrauma patient. Anaesthesia. 2008;63:1001-5.

  11. Marx H, Amin P, Lazarus JH. Hyperthyroidism and pregnancy. BMJ. 2008;336:663-7.

  12. Pimental L, Hansen K. Thyroid disease in the emergency department: a clinical and laboratory review. J Emerg Med. 2005;28:201-9.

  13. Panzer C, Beazley R, Braverman L. Rapid preoperative preparation for severe hyperthyroid Graves' disease. J Clin Endocrinol Metab. 2004;89:2142-4.

  14. Colectivo de autores. Consenso en el diagnóstico y tratamiento de las afecciones del tiroides. Rev Cubana Endocrinol. 2004;15:50-72.

  15. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22:263-77.

  16. Sarlis NJ, Gourgiotis L. Thyroid emergencies. Rev Endocr Metab Disord. 2003;4:129-36.

  17. Wartofsky L. Thyrotoxic storm. In: Braverman LE, Utiger RD, editors. Werner's & Ingbar's The thyroid. 9th edition. Philadelphia: Lipincott, Williams & Wilkins; 2005. p. 652-7.

  18. Burman KD, Monchik JM, Earll JM. Ionized and total serum calcium and parathyroid hormone in hyperthyroidism. Ann Intern Med. 1976;84:668-71.

  19. Dluhy RG. The adrenal cortex in thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner's & Ingbar's The thyroid. 9th edition. Philadelphia: Lipincott, Williams & Wilkins; 2005. p. 602-3.

  20. Wald D. ECG manifestations of selected metabolic and endocrine disorders. Emerg Med Clin North Am. 2006;24:145-57.

  21. Presti CE, Hart RG. Thyrotoxicosis, atrial fibrillation, and embolism, revisited. Am Heart J. 1989;117:976-7.

  22. Manrique Hurtado H. Tormenta tiroidea. En: Asociación Peruana de Endocrinología y Metabolismo, editor. Manual de emergencias endocrinas. Lima: FAH; 2004. p. 44-53.

  23. Herranz de la Morena L, Fernández Martínez A. Hipertiroidismo. Etiopatogenia. Clínica. Diagnóstico. Tratamiento. Medicine. 2004;9:856-65.

  24. McKeown NJ, Tews MC, Gossain V. Hyperthyroidism. Emerg Med Clin N Amer. 2005;23:669-85.

  25. Tietgens ST, Leinung MC. Thyroid storm. Med Clin North Am. 1995;79:169-84.

  26. Yeung S, Go R, Balasubramanyam A. Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm. Thyroid. 1995;5:403-5.

  27. Jongjaroenprasert W, Akarawut W, Chantasart D. Rectal administration of propylthiouracil in hyperthyroid patients: comparison of suspension enema and suppository form. Thyroid. 2002;12:627-31.

  28. Cooper D. Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner's & Ingbar's. The thyroid. 9th edition. Philadelphia: Lipincott, Williams & Wilkins; 2005. p. 665-94.

  29. Langley RW, Burch HB. Perioperative management of the thyrotoxic patient. Endocrinol Metab Clin North Am. 2003;32:519-34.

  30. Klein I, Ojamaa K. Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am. 1998;27:51-61.

  31. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725-35.




2020     |     www.medigraphic.com